Uni Chem Co., Ltd.

As of June 30, 2026, Uni Chem Co., Ltd. carries a market capitalization of 34.72B, placing it among publicly traded companies globally. Its enterprise value stands at 107.01B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Uni Chem Co., Ltd. has 9.02M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.34, and the price-to-book ratio stands at 0.28.

These figures are as of June 30, 2026. The EV/Sales ratio of 1.03 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 107.01B versus a market cap of 34.72B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Uni Chem Co., Ltd. maintains a current ratio of 2.46, meaning it holds 2.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 62.05, indicating elevated leverage, while an interest coverage ratio of -0.11 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Uni Chem Co., Ltd. posted a negative return on equity (ROE) of -11.48, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -6.76, reflecting losses generated across the asset base. The company generates approximately 411.20M in revenue per employee across its workforce of 253.50, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.45 indicates how many times Uni Chem Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Uni Chem Co., Ltd. recorded 3.09B in income tax expense. The company reported a pretax loss of -11.21B and -14.13B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Uni Chem Co., Ltd.'s stock has declined approximately 49.82% over the past 52 weeks. The 50-day moving average sits at 4,831.80, while the 200-day moving average is 7,180.25.

Over the twelve months ended June 30, 2026, Uni Chem Co., Ltd. generated 104.24B in revenue and converted that into -14.13B in net income, yielding earnings per share of -1,574.18. EBITDA reached -673.65M, while operating income came in at -6.40B.

As of June 30, 2026, Uni Chem Co., Ltd. holds 2.70B in cash and equivalents against 76.10B in total debt, resulting in a net debt position of 73.59B. Total book value stands at 123.74B, with working capital of 65.89B providing operational flexibility.

Uni Chem Co., Ltd. produced -16.07B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -6.11B in capital expenditures, free cash flow totaled -22.18B - equivalent to -2,441.56 per share.

Over the twelve months ended June 30, 2026, Uni Chem Co., Ltd. posted a gross margin of 3.53, reflecting its pricing power and cost economics. The operating margin of -6.14 and net profit margin of -13.55 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -63.42: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -67.24, meaning Uni Chem Co., Ltd. raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Uni Chem Co., Ltd.'s most recent stock split took place on June 30, 2026 with a 10:1 split ratio.

As of June 30, 2026, Uni Chem Co., Ltd. has an Altman Z-Score of 0.96, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.